Growth Summit Presentation

Alyea Therapeutics CEO Amol Soin will present at the 2026 Toronto Growth Summit.

Alyea Therapeutics, a wholly owned subsidiary of AIFC Corporation (NASDAQ: AIFC), is set to participate in the 3rd Annual ArcStone-Kingswood Growth Summit 2026 in Toronto. Amol Soin, CEO of Alyea Theraputics, will participate as a Featured Company and will hold one-on-one meetings with interested investors and capital markets professionals. The summit will host growth issuers and a curated group of investors, family offices, institutional investors, capital market professionals and service providers for a full day of company presentations, networking, and 1-on.1 meetings. The conference programme will also provide keynote presentation, panel discussions and conversations on industry developments. Interested investors can register for a free pass here.